Browse by Changes
Summary of Changes – 1 July 2025
Page last updated: 1 July 2025
Previous versions of the Summary of Changes are available in PDF in the Publications Archive.
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
General Pharmaceutical Benefits
Additions
Addition – Item
14869N | AZITHROMYCIN, azithromycin 500 mg tablet, 3 (Azithromycin Tablets, USP 500 mg (Precision Dose, USA)) |
14870P | AZITHROMYCIN, azithromycin 500 mg tablet, 3 (Azithromycin Tablets, USP 500 mg (Precision Dose, USA)) |
14875X | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 28 (Slinda) |
14852Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Nepexto) |
14864H | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14873T | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14868M | IVOSIDENIB, ivosidenib 250 mg tablet, 60 (Tibsovo) |
14857Y | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 60 (Concerta (Switzerland)) |
14861E | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 30 (Concerta (Switzerland)) |
14874W | METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30 (Concerta (Switzerland)) |
14858B | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 30 (Concerta (Switzerland)) |
14862F | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 60 (Concerta (Switzerland)) |
14853R | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30 (Concerta (Switzerland)) |
14871Q | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 60 (Concerta (Switzerland)) |
14854T | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) |
14851P | RIBOCICLIB, ribociclib 200 mg tablet, 21 (Kisqali) |
14863G | RIBOCICLIB, ribociclib 200 mg tablet, 42 (Kisqali) |
Addition – Brand
10219W | ARIPENA, RA – ARIPIPRAZOLE, aripiprazole 400 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack |
11198J | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11201M | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11202N | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11215G | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11218K | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11221N | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11222P | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13687J | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13697X | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13708L | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13774Y | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
1964J | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
3447K | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
3450N | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9455P | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9456Q | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9457R | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9458T | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9459W | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9460X | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9461Y | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9462B | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
5262Y | FILOSIR, NM – FINGOLIMOD, fingolimod 500 microgram capsule, 28 |
14005D | APOHEALTH Urinary Tract Antibacterial, TX – METHENAMINE HIPPURATE, methenamine hippurate 1 g tablet, 100 |
14005D | Chemists' Own Urinary Tract Antibacterial, RW – METHENAMINE HIPPURATE, methenamine hippurate 1 g tablet, 100 |
3124K | APOHEALTH Urinary Tract Antibacterial, TX – METHENAMINE HIPPURATE, methenamine hippurate 1 g tablet, 100 |
3124K | Chemists' Own Urinary Tract Antibacterial, RW – METHENAMINE HIPPURATE, methenamine hippurate 1 g tablet, 100 |
12192Q | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 2.5 mg tablet, 60 |
12197Y | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 2.5 mg tablet, 60 |
13366L | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 2.5 mg tablet, 60 |
11633G | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
11633G | Rivarelto, XW – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
13521P | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
13521P | Rivarelto, XW – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
9466F | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 10 mg tablet, 15 |
9467G | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
9467G | Rivarelto, XW – RIVAROXABAN, rivaroxaban 10 mg tablet, 30 |
9469J | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 10 mg tablet, 15 |
13463N | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
13463N | Rivarelto, XW – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
2160Q | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 15 mg tablet, 42 |
2160Q | Rivarelto, XW – RIVAROXABAN, rivaroxaban 15 mg tablet, 42 |
2691P | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
2691P | Rivarelto, XW – RIVAROXABAN, rivaroxaban 15 mg tablet, 28 |
13462M | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
13462M | Rivarelto, XW – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
2268J | APO-Rivaroxaban, TX – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
2268J | Rivarelto, XW – RIVAROXABAN, rivaroxaban 20 mg tablet, 28 |
11123K | Omtralo, NM – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
11123K | Sacubitril/Valsartan Alphapharm, FY – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
13570F | Omtralo, NM – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
13570F | Sacubitril/Valsartan Alphapharm, FY – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
11131W | Omtralo, NM – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
11131W | Sacubitril/Valsartan Alphapharm, FY – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
13511D | Omtralo, NM – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
13511D | Sacubitril/Valsartan Alphapharm, FY – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
11122J | Omtralo, NM – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
11122J | Sacubitril/Valsartan Alphapharm, FY – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
13445P | Omtralo, NM – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
13445P | Sacubitril/Valsartan Alphapharm, FY – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
Addition – Equivalence Indicator
10219W | Abilify Maintena, LU – ARIPIPRAZOLE, aripiprazole 400 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack |
14791L | Slinda, HB – DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 |
14737P | Vabysmo, RO – FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
14738Q | Vabysmo, RO – FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
1658G | Phebra Naproxen Suspension, FF – NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL |
14844G | Ozempic, NO – SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device |
14846J | Ozempic, NO – SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device |
Addition – Note
8200N | AZITHROMYCIN, azithromycin 500 mg tablet, 2 (APO-Azithromycin, AZITHROMYCIN-WGR, Azithromycin Sandoz, Azithromycin Viatris, ZITHRO, Zithromax) |
8336R | AZITHROMYCIN, azithromycin 500 mg tablet, 2 (APO-Azithromycin, AZITHROMYCIN-WGR, Azithromycin Sandoz, Azithromycin Viatris, ZITHRO, Zithromax) |
14791L | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 (Slinda) |
1954W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
1964J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
1963H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
2387P | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
2172H | METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
2388Q | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
2432B | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
1658G | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension) |
14844G | SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device (Ozempic) |
14846J | SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device (Ozempic) |
Deletions
Deletion – Item
14050L | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
2426Q | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
5038E | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
13918M | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
2431Y | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
5037D | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
1288T | DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex) |
5565X | DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex) |
14668B | EZETIMIBE, ezetimibe 10 mg tablet, 90 (Ezetimibe USP (Camber, USA)) |
14682R | EZETIMIBE, ezetimibe 10 mg tablet, 90 (Ezetimibe USP (Camber, USA)) |
Deletion – Brand
1007B | Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 200 mg tablet, 90 |
13358C | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 100 mg tablet, 200 |
2600W | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 100 mg tablet, 200 |
13532F | Amlodipine APOTEX, GX – AMLODIPINE, amlodipine 5 mg tablet, 30 |
2751T | Amlodipine APOTEX, GX – AMLODIPINE, amlodipine 5 mg tablet, 30 |
1887H | Cilamox, AL – AMOXICILLIN, amoxicillin 250 mg/5 mL powder for oral liquid, 100 mL |
3393N | Cilamox, AL – AMOXICILLIN, amoxicillin 250 mg/5 mL powder for oral liquid, 100 mL |
8844L | Bivalirudin APOTEX, TX – BIVALIRUDIN, bivalirudin 250 mg injection, 1 vial |
2460L | Aclor 125, MQ – CEFACLOR, cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
5046N | Aclor 125, MQ – CEFACLOR, cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
2461M | Aclor 250, MQ – CEFACLOR, cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
5047P | Aclor 250, MQ – CEFACLOR, cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
1169M | Karlor CD, MQ – CEFACLOR, cefaclor 375 mg modified release tablet, 10 |
5045M | Karlor CD, MQ – CEFACLOR, cefaclor 375 mg modified release tablet, 10 |
13385L | Zeklen 10/10 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
9483D | Zeklen 10/10 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
13442L | Zeklen 10/20 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
9484E | Zeklen 10/20 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
13535J | Zeklen 10/40 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
8881K | Zeklen 10/40 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
13595M | Zeklen 10/80 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
8882L | Zeklen 10/80 mg, AF – EZETIMIBE + SIMVASTATIN, ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
13377C | Fendex ER, AF – FELODIPINE, felodipine 2.5 mg modified release tablet, 30 |
2361G | Fendex ER, AF – FELODIPINE, felodipine 2.5 mg modified release tablet, 30 |
13561R | Fendex ER, AF – FELODIPINE, felodipine 5 mg modified release tablet, 30 |
2366M | Fendex ER, AF – FELODIPINE, felodipine 5 mg modified release tablet, 30 |
13531E | Fendex ER, AF – FELODIPINE, felodipine 10 mg modified release tablet, 30 |
2367N | Fendex ER, AF – FELODIPINE, felodipine 10 mg modified release tablet, 30 |
14740T | Glyade MR, AF – GLICLAZIDE, gliclazide 30 mg modified release tablet, 100 |
8535F | Glyade MR, AF – GLICLAZIDE, gliclazide 30 mg modified release tablet, 100 |
13848W | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 1 mg tablet, 30 |
8450R | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 1 mg tablet, 30 |
13870B | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 2 mg tablet, 30 |
8451T | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 2 mg tablet, 30 |
14020X | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 3 mg tablet, 30 |
8533D | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 3 mg tablet, 30 |
14055R | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 4 mg tablet, 30 |
8452W | Glimepiride APOTEX, GX – GLIMEPIRIDE, glimepiride 4 mg tablet, 30 |
2546B | Aldiq, AF – IMIQUIMOD, imiquimod 5% cream, 12 x 250 mg sachets |
1542E | Ipratrin, AF – IPRATROPIUM, ipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules |
8238N | Ipratrin Adult, AF – IPRATROPIUM, ipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules |
13940Q | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
14068K | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
5449T | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
8374R | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 10 mg tablet, 30 |
13998R | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
14069L | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
5450W | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
8375T | Leflunomide APOTEX, GX – LEFLUNOMIDE, leflunomide 20 mg tablet, 30 |
13411W | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 10 mg tablet, 28 |
8534E | Lercanidipine APOTEX, GX – LERCANIDIPINE, lercanidipine hydrochloride 10 mg tablet, 28 |
13939P | Letrozole APOTEX, GX – LETROZOLE, letrozole 2.5 mg tablet, 30 |
8245Y | Letrozole APOTEX, GX – LETROZOLE, letrozole 2.5 mg tablet, 30 |
13992K | Kevtam 250, AF – LEVETIRACETAM, levetiracetam 250 mg tablet, 60 |
13992K | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 250 mg tablet, 60 |
8654L | Kevtam 250, AF – LEVETIRACETAM, levetiracetam 250 mg tablet, 60 |
8654L | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 250 mg tablet, 60 |
14034P | Kevtam 500, AF – LEVETIRACETAM, levetiracetam 500 mg tablet, 60 |
8655M | Kevtam 500, AF – LEVETIRACETAM, levetiracetam 500 mg tablet, 60 |
13937M | Kevtam 1000, AF – LEVETIRACETAM, levetiracetam 1 g tablet, 60 |
13937M | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 1 g tablet, 60 |
8656N | Kevtam 1000, AF – LEVETIRACETAM, levetiracetam 1 g tablet, 60 |
8656N | Levetiracetam Mylan, AL – LEVETIRACETAM, levetiracetam 1 g tablet, 60 |
10526B | Latuda, SE – LURASIDONE, lurasidone hydrochloride 40 mg tablet, 30 |
10529E | Latuda, SE – LURASIDONE, lurasidone hydrochloride 80 mg tablet, 30 |
1653B | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
1654C | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
1655D | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
1656E | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
3010K | Nufloxib, AF – NORFLOXACIN, norfloxacin 400 mg tablet, 14 |
8170B | Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 2.5 mg tablet, 28 |
11681T | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
12277E | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
14330F | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
14362X | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
14394N | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
8007K | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
8008L | Pantoprazole APOTEX, TY – PANTOPRAZOLE, pantoprazole 40 mg enteric tablet, 30 |
13588E | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30 |
2574L | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 20 mg tablet, 30 |
13589F | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30 |
2594M | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 40 mg tablet, 30 |
11856B | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
14027G | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
8144P | IMIGRAN MIGRAINE, AS – SUMATRIPTAN, sumatriptan 50 mg tablet, 2 |
8144P | Imigran, LN – SUMATRIPTAN, sumatriptan 50 mg tablet, 2 |
Deletion – Equivalence Indicator
8844L | BIVALIRUDIN ARX, XT – BIVALIRUDIN, bivalirudin 250 mg injection, 1 vial |
14671E | Tegretol CR 200, NV – CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 |
14673G | Tegretol CR 200, NV – CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 |
14681Q | Tegretol CR 200, NV – CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 |
14662Q | Tegretol CR 400, NV – CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 |
14666X | Tegretol CR 400, NV – CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 |
14680P | Tegretol CR 400, NV – CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 |
1542E | Atrovent, BY – IPRATROPIUM, ipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules |
8238N | Atrovent Adult, BY – IPRATROPIUM, ipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules |
Deletion – Note
13897K | ALOGLIPTIN, alogliptin 6.25 mg tablet, 28 (Nesina) |
2944Y | ALOGLIPTIN, alogliptin 6.25 mg tablet, 28 (Nesina) |
13977P | ALOGLIPTIN, alogliptin 12.5 mg tablet, 28 (Nesina) |
2933J | ALOGLIPTIN, alogliptin 12.5 mg tablet, 28 (Nesina) |
13953J | ALOGLIPTIN, alogliptin 25 mg tablet, 28 (Nesina) |
2986E | ALOGLIPTIN, alogliptin 25 mg tablet, 28 (Nesina) |
10035E | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 1 g tablet, 56 (Nesina Met 12.5/1000) |
13989G | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 1 g tablet, 56 (Nesina Met 12.5/1000) |
10033C | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 56 (Nesina Met 12.5/500) |
14062D | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 56 (Nesina Met 12.5/500) |
10032B | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 56 (Nesina Met 12.5/850) |
14061C | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 56 (Nesina Met 12.5/850) |
14671E | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
14673G | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
14681Q | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
14662Q | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
14666X | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
14680P | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
13440J | EZETIMIBE, ezetimibe 10 mg tablet, 30 (APO-Ezetimibe, ARX-EZETIMIBE, BTC Ezetimibe, EZEMICHOL, EZETIMIBE-WGR, Ezetimibe GH, Ezetimibe Sandoz, Ezetrol, Pharmacor Ezetimibe 10, Zient 10mg) |
8757X | EZETIMIBE, ezetimibe 10 mg tablet, 30 (APO-Ezetimibe, ARX-EZETIMIBE, BTC Ezetimibe, EZEMICHOL, EZETIMIBE-WGR, Ezetimibe GH, Ezetimibe Sandoz, Ezetrol, Pharmacor Ezetimibe 10, Zient 10mg) |
Alterations
Alteration – Item Description
From | |
14378R | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
To | |
14378R | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
From | |
14540G | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
To | |
14540G | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
From | |
8406K | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
To | |
8406K | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
From | |
8408M | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
To | |
8408M | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
From | |
14514X | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
To | |
14514X | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
From | |
14541H | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
To | |
14541H | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
From | |
8407L | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
To | |
8407L | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
From | |
8409N | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
To | |
8409N | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
Alteration – Note
11207W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11223Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3445H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3448L | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8778B | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9035M | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9036N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9037P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9429G | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11198J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11202N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11221N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11222P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
13687J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
13774Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
3447K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
3450N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9455P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9457R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9458T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9461Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9462B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11208X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11216H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
11224R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11225T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
13698Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
13751R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
3446J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
3449M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9085E | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9087G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9088H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9091L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9431J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
14737P | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
14738Q | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
Alteration – Restriction
14116Y | ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio) |
14105J | ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio) |
14134X | ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio) |
11204Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11207W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11223Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3445H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3448L | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8638P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8778B | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8779C | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9035M | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9036N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9037P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9429G | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11198J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11201M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11202N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11221N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11222P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
3447K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
3450N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9455P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9456Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9457R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9458T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9460X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9461Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9462B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11196G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11208X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11216H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
11224R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11225T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
3446J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
3449M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9085E | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9086F | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9087G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9088H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9090K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9091L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9431J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
14181J | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
14216F | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
14208T | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
14215E | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
Alteration – Manufacturer Code
From | To | ||
13032X | Ruzurgi – AMIFAMPRIDINE, amifampridine 10 mg tablet, 100 | OJ | LD |
12652X | Reagila – CARIPRAZINE, cariprazine 1.5 mg capsule, 30 | CS | IX |
12619E | Reagila – CARIPRAZINE, cariprazine 3 mg capsule, 30 | CS | IX |
12653Y | Reagila – CARIPRAZINE, cariprazine 4.5 mg capsule, 30 | CS | IX |
12622H | Reagila – CARIPRAZINE, cariprazine 6 mg capsule, 30 | CS | IX |
11123K | Valtresto – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | RM | TX |
13570F | Valtresto – SACUBITRIL + VALSARTAN, sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | RM | TX |
11131W | Valtresto – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | RM | TX |
13511D | Valtresto – SACUBITRIL + VALSARTAN, sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | RM | TX |
11122J | Valtresto – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | RM | TX |
13445P | Valtresto – SACUBITRIL + VALSARTAN, sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | RM | TX |
Supply Only
Supply Only – Period Commencing
14335L | GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 (Minitran 15) |
8119H | GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 (Minitran 15) |
Supply Only – Period Ending
5519L | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
8564R | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
9215B | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
Supply Only – Addition Equivalence Indicator
This change will impact items which are currently available for supply only
12080T | Ozempic, NO – SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device |
14149Q | Ozempic, NO – SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device |
Supply Only – Addition Note
This change will impact items which are currently available for supply only
12080T | SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device (Ozempic) |
14149Q | SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device (Ozempic) |
Advance Notices
1 August 2025
Deletion – Brand
1052J | Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 800 mg tablet, 35 |
11329G | Giotrif, BY – AFATINIB, afatinib 50 mg tablet, 28 |
11342Y | Giotrif, BY – AFATINIB, afatinib 50 mg tablet, 28 |
9438R | GA gel, VF – AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN, amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 24 g sachets |
14425F | Betoptic, NV – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
2825Q | Betoptic, NV – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
5544T | Betoptic, NV – BETAXOLOL, betaxolol 0.5% eye drops, 5 mL |
8878G | Durogesic 12, JC – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
8891Y | Durogesic 25, JC – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
8892B | Durogesic 50, JC – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
8893C | Durogesic 75, JC – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
8894D | Durogesic 100, JC – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
8729K | Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
8730L | Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
14526M | Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
14526M | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
8627C | Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
8627C | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
14194C | RA-Morph (NZ), WZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
14204N | RA-Morph (NZ), WZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
10005N | Olmekar HCT 20/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
13481M | Olmekar HCT 20/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
13482N | Olmekar HCT 40/10/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
13512E | Olmekar HCT 40/5/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
13513F | Olmekar HCT 40/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
14002Y | Olmekar HCT 40/10/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
2836G | Olmekar HCT 40/10/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
2864R | Olmekar HCT 40/5/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
2880N | Olmekar HCT 40/5/12.5, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
2953K | Olmekar HCT 40/10/25, RF – OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE, olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
14367E | Noumed Paroxetine, VO – PAROXETINE, paroxetine 20 mg tablet, 30 |
2242B | Noumed Paroxetine, VO – PAROXETINE, paroxetine 20 mg tablet, 30 |
8589C | Accuretic 10/12.5mg, PF – QUINAPRIL + HYDROCHLOROTHIAZIDE, quinapril 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
8590D | Accuretic 20/12.5mg, PF – QUINAPRIL + HYDROCHLOROTHIAZIDE, quinapril 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
8527T | Metalyse, BY – TENECTEPLASE, tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack |
14636H | Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA), KQ – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
10622C | Hymenoptera Yellow Jacket Venom, DE – YELLOW JACKET VENOM, yellow jacket venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial], 1 pack |
1 September 2025
Deletion – Brand
1555W | Aciclovir APOTEX, TY – ACICLOVIR, aciclovir 200 mg tablet, 50 |
13575L | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 300 mg tablet, 60 |
2604C | Allopurinol APOTEX, GX – ALLOPURINOL, allopurinol 300 mg tablet, 60 |
5296R | Riamet 20mg/120mg Dispersible, NV – ARTEMETHER + LUMEFANTRINE, artemether 20 mg + lumefantrine 120 mg dispersible tablet, 18 |
5265D | Denpax, AF – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
5277R | Denpax, AF – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
5278T | Denpax, AF – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
5279W | Denpax, AF – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
5280X | Denpax, AF – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
10915L | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
10918P | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
10920R | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
10924Y | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
10940T | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
10941W | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
10942X | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
11757T | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
11770L | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
11776T | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
11777W | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
11782D | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
11783E | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
11875B | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
12709X | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
12710Y | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
12722N | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
12759M | Imatinib-APOTEX, TX – IMATINIB, imatinib 100 mg capsule, 60 |
14553Y | Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
14553Y | Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
8628D | Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
8628D | Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
13449W | Olmesartan/Amlodipine 20/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
5292M | Olmesartan/Amlodipine 20/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
13898L | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 15 mg tablet, 28 |
8694N | APOTEX-Pioglitazone, TX – PIOGLITAZONE, pioglitazone 15 mg tablet, 28 |
13406N | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30 |
2606E | Rosuvastatin APOTEX, GX – ROSUVASTATIN, rosuvastatin 5 mg tablet, 30 |
1 October 2025
Deletion – Brand
13419G | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 2.5 mg tablet, 28 |
13443M | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 5 mg tablet, 28 |
13444N | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 10 mg tablet, 28 |
8604W | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 2.5 mg tablet, 28 |
8605X | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 5 mg tablet, 28 |
8606Y | NOUMED BISOPROLOL, VO – BISOPROLOL, bisoprolol fumarate 10 mg tablet, 28 |
1475P | Fluconazole APOTEX, GX – FLUCONAZOLE, fluconazole 200 mg capsule, 28 |
14526M | Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
14526M | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
14553Y | Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
14553Y | Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
8627C | Montelukast APOTEX, GX – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
8627C | Montelukast Mylan, AF – MONTELUKAST, montelukast 4 mg chewable tablet, 28 |
8628D | Montelukast APOTEX, GX – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
8628D | Montelukast Mylan, AF – MONTELUKAST, montelukast 5 mg chewable tablet, 28 |
8185T | Olanzapine APOTEX, GX – OLANZAPINE, olanzapine 5 mg tablet, 28 |
13964Y | Olmesartan/Amlodipine 40/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
5293N | Olmesartan/Amlodipine 40/5 APOTEX, TX – OLMESARTAN + AMLODIPINE, olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
5470X | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 4 |
5472B | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 10 |
13997Q | Tamosin, OX – TAMOXIFEN, tamoxifen 20 mg tablet, 60 |
2110C | Tamosin, OX – TAMOXIFEN, tamoxifen 20 mg tablet, 60 |
Palliative Care
Additions
Addition – Item
14867L | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) |
Addition – Equivalence Indicator
5397C | Phebra Naproxen Suspension, FF – NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL |
Addition – Note
5397C | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension) |
Deletions
Deletion – Brand
12547J | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
12500X | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
12544F | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
12483B | Morphine MR Mylan, AF – MORPHINE, morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
Advance Notices
1 August 2025
Deletion – Brand
12474M | Durogesic 75, JC – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
12477Q | Durogesic 50, JC – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
12504D | Durogesic 25, JC – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
12509J | Durogesic 100, JC – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
12541C | Durogesic 12, JC – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
14187Q | RA-Morph (NZ), WZ – MORPHINE, morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
1 September 2025
Deletion – Brand
12491K | Denpax, AF – FENTANYL, fentanyl 12 microgram/hour patch, 5 |
12516R | Denpax, AF – FENTANYL, fentanyl 25 microgram/hour patch, 5 |
12526G | Denpax, AF – FENTANYL, fentanyl 75 microgram/hour patch, 5 |
12533P | Denpax, AF – FENTANYL, fentanyl 100 microgram/hour patch, 5 |
12546H | Denpax, AF – FENTANYL, fentanyl 50 microgram/hour patch, 5 |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
14865J | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Addition – Brand
13326J | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9641K | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
Addition – Note
6367D | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
Addition – Caution
13326J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9641K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13332Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9615C | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Deletions
Deletion – Brand
12139X | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12143D | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12148J | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
6429J | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
11838C | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
Deletion – Note
14189T | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Deletion – Restriction
14189T | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Alterations
Alteration – Note
14279M | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14280N | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13266F | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12938Y | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
13326J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9641K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13332Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9615C | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Alteration – Restriction
14279M | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14280N | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13266F | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12938Y | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
14856X | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Addition – Brand
13319B | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
5735W | Nepexto, GQ – ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
Addition – Note
5734T | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
Addition – Caution
13319B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
5735W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13308K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
5733R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Deletions
Deletion – Brand
12134P | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12140Y | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
12145F | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
5618Q | Bosentan Mylan, AF – BOSENTAN, bosentan 62.5 mg tablet, 60 |
11855Y | Sevelamer Apotex, TX – SEVELAMER, sevelamer carbonate 800 mg tablet, 180 |
Deletion – Note
14195D | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Deletion – Restriction
14195D | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Alterations
Alteration – Note
14227T | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14228W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13276R | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12936W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
13319B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
5735W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13308K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
5733R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Alteration – Restriction
14227T | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14228W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13276R | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12936W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
Highly Specialised Drugs Program (Community Access)
Additions
Addition – Item
14866K | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Advance Notices
1 August 2025
Deletion – Brand
10310P | Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
11992E | Tenofovir APOTEX, TX – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
14637J | Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA), KQ – TENOFOVIR DISOPROXIL + EMTRICITABINE, tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
1 October 2025
Deletion – Brand
10348P | Lamivudine Alphapharm, AF – LAMIVUDINE, lamivudine 150 mg tablet, 60 |
10310P | Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
11992E | Viread, GI – TENOFOVIR DISOPROXIL, tenofovir disoproxil fumarate 300 mg tablet, 30 |
Repatriation Pharmaceutical Benefits
Deletions
Deletion – Item
4571N | NICOTINE, nicotine 7 mg/24 hours patch, 7 (QuitX) |
4572P | NICOTINE, nicotine 14 mg/24 hours patch, 7 (QuitX) |
4573Q | NICOTINE, nicotine 21 mg/24 hours patch, 7 (QuitX) |
Deletion – Brand
4134N | Aldiq, AF – IMIQUIMOD, imiquimod 5% cream, 12 x 250 mg sachets |
4559Y | Aldiq, AF – IMIQUIMOD, imiquimod 5% cream, 12 x 250 mg sachets |
Advance Notices
1 August 2025
Deletion – Brand
4468E | Rynacrom, SW – CROMOGLYCATE, sodium cromoglycate 2% nasal spray, 26 mL |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
14860D |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
14872R |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Addition – Brand
10763L | BENDAMUSTINE EUGIA, YG – BENDAMUSTINE, bendamustine hydrochloride 25 mg injection, 1 vial |
10763L | BENDAMUSTINE EUGIA, YG – BENDAMUSTINE, bendamustine hydrochloride 100 mg injection, 1 vial |
7249M | IRINOTECAN EUGIA, YG – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
7249M | IRINOTECAN EUGIA, YG – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Deletions
Deletion – Brand
7229L | Adriamycin, PF – DOXORUBICIN, doxorubicin hydrochloride 200 mg/100 mL injection, 100 mL vial |
7249M | Omegapharm Irinotecan, OE – IRINOTECAN, irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 2 mL vial |
7249M | Irinotecan Alphapharm, AF – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
7249M | Omegapharm Irinotecan, OE – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
7249M | Irinotecan Alphapharm, AF – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Alterations
Alteration – Manufacturer Code
From | To | ||
10383L | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
10402L | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
10589H | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
10597R | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
7264H | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
7265J | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
7266K | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
7267L | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
Advance Notices
1 August 2025
Deletion – Brand
10699D | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
7241D | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
12219D | Bortezomib Sandoz, SZ – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial |
7234R | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
7234R | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
7239B | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
7239B | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
14855W |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
14859C |
NIVOLUMAB, nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo); nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Addition – Brand
10760H | BENDAMUSTINE EUGIA, YG – BENDAMUSTINE, bendamustine hydrochloride 25 mg injection, 1 vial |
10760H | BENDAMUSTINE EUGIA, YG – BENDAMUSTINE, bendamustine hydrochloride 100 mg injection, 1 vial |
4451G | IRINOTECAN EUGIA, YG – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
4451G | IRINOTECAN EUGIA, YG – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Deletions
Deletion – Brand
4361M | Adriamycin, PF – DOXORUBICIN, doxorubicin hydrochloride 200 mg/100 mL injection, 100 mL vial |
4451G | Omegapharm Irinotecan, OE – IRINOTECAN, irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 2 mL vial |
4451G | Irinotecan Alphapharm, AF – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
4451G | Omegapharm Irinotecan, OE – IRINOTECAN, irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
4451G | Irinotecan Alphapharm, AF – IRINOTECAN, irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Alterations
Alteration – Manufacturer Code
From | To | ||
10391X | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
10401K | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
10581X | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
10588G | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
4632T | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
4639E | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
4650R | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
4703M | Kanjinti – TRASTUZUMAB, trastuzumab 420 mg injection, 1 vial | JU | XT |
Advance Notices
1 August 2025
Deletion – Brand
10691Q | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
4371C | Arsenic Trioxide-AFT, AE – ARSENIC, arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
12227M | Bortezomib Sandoz, SZ – BORTEZOMIB, bortezomib 3.5 mg injection, 1 vial |
4394G | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
4394G | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
4431F | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 1 g/20 mL injection, 20 mL vial |
4431F | Fluorouracil Ebewe, SZ – FLUOROURACIL, fluorouracil 5 g/100 mL injection, 100 mL vial |
Related Pharmaceutical Benefits for Public Hospital use
Advance Notices
1 August 2025
Deletion – Brand
5899L | Granisetron-AFT, AE – GRANISETRON, granisetron 3 mg/3 mL injection, 3 mL ampoule |
1 October 2025
Deletion – Brand
5857G | Ondansetron Mylan ODT, AF – ONDANSETRON, ondansetron 4 mg orally disintegrating tablet, 4 |